Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 4039-4046
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4039
Figure 2
Figure 2 Systemic IL-9 in patients with active and inactive Crohn’s disease and ulcerative colitis. Data presented as geometric means with 95%CI and analyzed using one-way ANOVA. Small letters indicate statistical significance of between-group differences.